Ping An Biomedical Co., Ltd.
PASWNASDAQIndustrials● Active
$0.18
+$0.02(+12.05%)
Market Cap$3333489
P/E Ratio—
52W High$5.4
52W Low$0.121
Ping An Biomedical Co., Ltd. (PASW) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · PASW · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2024-09 | 2023-09 | 2022-09 | 2021-09 |
|---|---|---|---|---|
| Revenue | ||||
| Revenue | $87.62M | $82.56M | $114.55M | $99.52M |
| Cost of Revenue | $82.21M | $78.32M | $100.40M | $85.25M |
| Gross Profit | $5.42M | $4.24M | $14.14M | $14.27M |
| Gross Margin %(computed) | 6.18% | 5.14% | 12.35% | 14.34% |
| Operating Expenses | ||||
| R&D Expenses | $0.00M | $0.00M | $0.00M | $0.00M |
| G&A Expenses | $4.54M | $2.88M | $2.76M | $2.93M |
| Total Operating Expenses | $5.42M | $3.63M | $3.33M | $6.00M |
| Operating Income | ($0.00M) | $0.61M | $10.82M | $8.27M |
| Operating Margin %(computed) | -0.00% | 0.74% | 9.44% | 8.31% |
| Interest Income | $0.00M | $0.16M | $0.04M | $0.00M |
| Interest Expense | $0.71M | $1.74M | $1.57M | $1.36M |
| Income Before Tax | ($0.68M) | $0.04M | $9.63M | $7.82M |
| Income Tax Expense | $0.60M | $1.04M | $2.40M | $2.61M |
| Net Income | ($1.28M) | ($0.99M) | $7.23M | $5.21M |
| Net Margin %(computed) | -1.47% | -1.20% | 6.31% | 5.24% |
| Per Share & EBITDA | ||||
| EPS (Basic) | $0.00 | $-0.05 | $0.35 | $0.38 |
| Wtd Avg Shares | 0.00M | 20.50M | 20.50M | 13.75M |
| EBITDA | $0.47M | $2.20M | $11.61M | $9.57M |
| EBITDA Margin %(computed) | 0.54% | 2.66% | 10.13% | 9.62% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · CNY · M
Explore more Ping An Biomedical Co., Ltd. data
About Ping An Biomedical Co., Ltd. (PASW) Income Statement
Ping An Biomedical Co., Ltd. (PASW) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2024, PASW reported revenue of $0.09B, gross profit of $0.01B (gross margin 6.18%), and net income of ($0.00B) — a net profit margin of -1.47%.
Frequently asked questions
PASW · 4 questionsPing An Biomedical Co., Ltd. (PASW) reported revenue of $0.09B for 2024, up 6.1% year-over-year.
PASW revenuePASW salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08